Cure8 research brief
Why This Matters
Sarcopenia is common in Crohn's disease and is linked to worse outcomes; a simple GNRI-based prediction tool could help identify at-risk patients without routine CT scanning.
Who Should Pay Attention
Adults with Crohn's disease, IBD clinicians, dietitians/nutritionists, and researchers interested in biomarkers for malnutrition/sarcopenia.
Study Snapshot
What To Know
This retrospective study compared three nutrition-related indices (GNRI, ALI, PNI) in 333 Crohn's patients and developed a nomogram combining the GNRI with clinical factors to predict CT-defined sarcopenia. The GNRI performed well, was stable across subgroups, and the GNRI-based model showed good discrimination in internal validation.
The paper suggests the GNRI could be a noninvasive surrogate to help identify patients at higher risk of sarcopenia and guide targeted nutritional assessment and interventions. This report is grounded in the article abstract and internal validation results; Cure8 did not review the full study beyond the supplied text.
Keep In Mind
Retrospective design and internal validation only; findings are based on CT-defined sarcopenia and need external validation before changing practice.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.